← Open Payments lookup

VIVIAN UMEUGO: Open Payments

NPI 1609371046 · UPPER MARLBORO, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,109 in 65 payments from 13 companies in 2025. Trend: 2023 $1,356 · 2024 $2,019 · 2025 $2,109

Food & beverage: $2,106Education: $4
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.7$392
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$392
Otsuka America Pharmaceutical, Inc.10$281
Supernus Pharmaceuticals, Inc.8$229
Teva Pharmaceuticals USA, Inc.6$210
Alkermes, Inc.8$203
Janssen Pharmaceuticals, Inc3$114
Vanda Pharmaceuticals Inc.3$89
Janssen Scientific Affairs, LLC1$58
ABBVIE INC.2$42

Products named: COBENFY, CAPLYTA, Qelbree, REXULTI, UZEDY, INVEGA SUSTENNA, ARISTADA, ABILIFY ASIMTUFII.

Industry payments across MD — which companies pay providers there.